![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
New Zealand Health Groups Strive To Enhance Clinical Trials
Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments...
Clinical Trials
Canadian And US Pharma Firms To Test Psychedelic Drugs In UK
To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a...
Clinical Trials
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110...
Clinical Trials
By 2027, Market For Oligonucleotides Will Be Worth $16.7 Bn
The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market...
Clinical Trials
A Multi-Drug Trial On Cancer Precision Medicine Has Begun
A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with rare cancers who need...
Clinical Trials
Digital Trials Evolving Due To Single, Connected Foundation
Clinical trials have expanded from 2,119 in 2000 to over 409,000 in 2022 (and counting). Not only has the number of trials increased, but...
Clinical Trials
NICE Offers Historical Clinical Funding To Kidney Cancer UK
Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read